Skye Bioscience (SKYE)
NASDAQ:SKYE
US Market
Holding SKYE?
Track your performance easily

Skye Bioscience (SKYE) Financial Statements

190 Followers

Skye Bioscience Financial Overview

Skye Bioscience's market cap is currently ―. The company's EPS TTM is $-3.907; its P/E ratio is -0.96; Skye Bioscience is scheduled to report earnings on August 9, 2024, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
Ebit$ -7.89M$ 4.58M$ -3.99M$ -24.67M$ -2.92M
Ebitda$ -7.61M$ 4.85M$ -3.96M$ -24.54M$ -2.89M
Net Income Common Stockholders$ -7.90M$ -5.02M$ -4.42M$ -24.98M$ -3.11M
Balance Sheet-
Cash Cash Equivalents And Short Term Investments$ 74.12M$ 83.34M$ 1.26M$ 5.13M$ 558.03K
Total Assets$ 87.26M$ 94.84M$ 11.94M$ 15.60M$ 2.24M
Total Debt$ 5.07M$ 4.84M$ 4.62M$ 4.43M$ 364.65K
Net Debt$ -69.05M$ -78.51M$ 3.36M$ -699.90K$ -193.38K
Total Liabilities$ 14.45M$ 15.95M$ 14.07M$ 13.91M$ 10.03M
Stockholders Equity$ 72.81M$ 78.88M$ -2.13M$ 1.70M$ -7.79M
Cash Flow-
Free Cash Flow$ -7.13M$ -3.57M$ -9.38M$ -4.06M$ -1.99M
Operating Cash Flow$ -7.09M$ -4.71M$ -3.84M$ -4.05M$ -1.99M
Investing Cash Flow$ -32.46K$ 1.14M$ -7.02K$ 1.07M-
Financing Cash Flow$ -2.10M$ 85.65M$ -22.65K$ 16.63M$ -123.41K
Currency in USD

Skye Bioscience Earnings and Revenue History

Skye Bioscience Debt to Assets

Skye Bioscience Cash Flow

Skye Bioscience Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis